Mrs Julie Ambrose, LPN in Bradford, MA - Licensed Vocational Nurse

Mrs Julie Ambrose, LPN is a Licensed Vocational Nurse based in Bradford, Massachusetts. Mrs Julie Ambrose is licensed to practice in Massachusetts (license number 61548) and her current practice location is 63 Laurel Ave, Bradford, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (978) 500-9124.

NPI number for Mrs Julie Ambrose is 1114231107 and her current mailing address is 63 Laurel Ave, Bradford, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114231107.

Contact Information

	Mrs Julie Ambrose, LPN
	63 Laurel Ave, Bradford, MA 01835-7270
	(978) 500-9124
	Not Available

Provider's Profile

Full Name	Mrs Julie Ambrose
Gender	Female
Speciality	Licensed Vocational Nurse
Location	63 Laurel Ave, Bradford, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1114231107
Provider Enumeration Date: 08/02/2010
Last Update Date: 08/02/2010

Medical Identifiers

Medical identifiers for Mrs Julie Ambrose such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114231107	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	61548 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Julie Ambrose is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Julie Ambrose, LPN 63 Laurel Ave, Bradford, MA 01835-7270 Ph: (978) 500-9124	Mrs Julie Ambrose, LPN 63 Laurel Ave, Bradford, MA 01835-7270 Ph: (978) 500-9124

News Archive

Forward Pharma files Form F-1 registration statement for initial public offering of shares

Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, today announced that it has filed a registration statement on Form F-1 with the United States Securities and Exchange Commission relating to a proposed initial public offering of its ordinary shares.

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

Operative drainage after pancreatic resection ‘should be abandoned'

Routine prophylactic drainage offers no benefits to patients undergoing pancreatic resection, say researchers.

FDA approves Akorn's ANDA for generic version of Dilaudid-HP Injection

Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.

Apache, ANSYS' RedHawk and Totem products achieve TSMC Phase I 20 nm certification

ANSYS and subsidiary Apache Design announced today that their RedHawk and Totem products achieved TSMC Phase I 20 nm certification. TSMC certified the tools for 20 nm design rule manuals (DRMs) and SPICE models.

Mrs Julie Ambrose, LPN - Licensed Vocational Nurse in Bradford, MA